CJC-1295 + Ipamorelin

What is CJC-1295 + Ipamorelin?

Ipamorelin

Ipamorelin is recognized as a "growth hormone-releasing peptide" (GHRP).

GHRPs facilitate a gradual growth hormone release, creating a pulse that mirrors the natural patterns of growth hormone (GH) release and Growth Hormone Releasing Hormones, enhancing the natural release of growth hormone.

Ipamorelin functions twofold. Initially, it amplifies the secretion of the natural growth hormone releasing hormone, leading to heightened growth hormone levels. Secondly, Ipamorelin suppresses the somatostatin hormone that inhibits growth hormone production. By eliminating obstacles to natural growth hormone production, Ipamorelin elevates the rate of growth hormone production. Increased growth hormone production contributes to a more youthful appearance and vitality.

Why CJC-1295 + Ipamorelin?

When Ipamorelin and CJC-1295 are skillfully blended, they enhance the body's production of HGH, providing a robust and consistent release. Ipamorelin initiates the HGH pulse, complemented by CJC-1295, which amplifies and sustains this pulse.

Combining CJC-1295 and Ipamorelin in therapy is common due to their synergistic effects. While CJC-1295 takes 1-4 hours to peak in the bloodstream, Ipamorelin acts swiftly. Ipamorelin's half-life is approximately 2 hours, leading to quicker clearance from the body. This peptide combination ensures a rapid onset facilitated by Ipamorelin and prolonged effects from CJC-1295.

The statements made within this website have not been evaluated by the US Food and Drug Administration. The products we offer are not intended to diagnose, treat, cure or prevent any disease. Human and animal consumption is prohibited.
All products on this site are for laboratory and research purposes only. Bodily introduction is strictly prohibited by law.  Additionally, there is no relationship or affiliation, implied or otherwise, between Chemvita and any medical professionals or other companies.